Tamiflu and mortality
Tamiflu has supposedly been held responsible by health experts for the deaths caused by internal bleeding, vomiting and cardiovascular events but we should be assured by our medicines regulatory body, the MHRA. In 2009, the drug was administered to more than 1.1 million people. 2 out of 13 fatalities reported were among teenagers under the age of 18 years and 8 of the 13 cases were aged between 18 and 64 years.
The anti-viral has also been associated with suicidal thoughts and one suicide attempt, psychotic episods, convulsions, hallucinations and nightmares. The box is labelled with all of the potential side effects but does not mention the fatalities reported.
From July 2009 to January 2010, 1,125,627 patients were given Tamiflu. Doctors stated that less than 10% of those taking the treatment probably had the virus.
Some experts believe that Tamiflu is about as effective as paracetamol and that it is not a cure and that there is no real evidence exits to sugest that it is going to be of benefit to one. The MHRA however have said that the risks and benefits are still enough to keep the anti-viral on the market and that it should be viewed as having a positive effect.
The MHRA also say that there was no evidence to sugest that Tamiflu was responsible for deaths and that the patient’s underlying health problems had not been taken into consideration.
Over 83 million people have taken Tamiflu and 17 million of these were children. The drug was administered in over 80 countries and by a substantial majority has proved how well tolerated and safe the drug is.
About the Author: Andres Hudson is freelance writer. Who has written Article on Cholesterol Reduction. For more information about Tamiflu, he recommends you to visit http://www.theonlineclinic.co.uk/
Processing your request, Please wait....
